Inventor

Thomas Hille

Inventor

Neuwied, DE

Overview

1992–2021

Patent span

Human necessities

Primary field (CPC A)

Patents· 57 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Kprimary

A61KPreparations for medical, dental or toiletry purposes32%

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations24%

A61LMethods or apparatus for sterilising materials or objects in general5%

C07DHeterocyclic compounds4%

Y10TTechnical subjects covered by former us classification4%

B01JChemical or physical processes, e.g. catalysis or colloid chemistry4%

C08GMacromolecular compounds obtained otherwise than by reactions only involving unsaturated carbon-to-carbon bonds4%

A61FFilters implantable into blood vessels3%

C08JWorking-up2%

A61MDevices for introducing media into, or onto, the body1%

PatentTitleYear

10,975,268Sealing sheet and adhesive tape for wet rooms2021 10,940,122Transdermal therapeutic system with fentanyl or related substances2021 10,583,093Transdermal therapeutic system with fentanyl or related substances2020 10,568,845Transdermal therapeutic system with fentanyl or related substances2020 10,335,377Over-patch having improved compatibility and a long adhesion duration and method for producing said over-patch2019 9,862,002'Process for producing a layer system'2018 9,670,323'Method for separating volatile substances from material mixtures and device for producing polyarylene sulfides'2017 9,616,045'Transdermal therapeutic system having improved long-term wearing comfort'2017 9,567,438'Method for separating volatile substances from material mixtures and device for producing polyarylene sulfides'2017 9,562,138'Method for separating volatile substances from material mixtures and device for producing polyarylene sulfides'2017 9,549,903'Transdermal delivery system comprising buprenorphine'2017 9,308,202'Transdermal therapeutic system for administering the active substance buprenorphine'2016 9,200,529'Method for adjusting the radial gaps which exist between blade airfoil tips or rotor blades and a passage wall'2015 9,101,605'Buprenorphine transdermal therapeutic system and method of administering'2015 9,089,527'Transdermal therapeutic system comprising ion pair microreservoirs'2015 8,883,198'Transdermal rivastigmine therapeutic system'2014 8,628,795'Transdermal therapeutic buprenorphine system'2014 8,207,159'Use of galanthamine for the treatment of pathological manifestations of the central nervous system based on intoxications with psychotropic substances'2012 8,142,594'Method for the multi-track tailoring of transdermal therapeutic patches'2012 8,075,912'Autodestructive transdermal therapeutic system'2011 7,824,707'Transdermal therapeutic system provided with improved long-term carrying comfort'2010 7,769,762'Method and system for consolidating data type repositories'2010 7,384,651'Transdermal therapeutic system comprising a reservoir type pressure sensitive adhesive layer and a back layer with uni-directional resilience'2008 7,259,227'Method for continuous production of high-molecular weight polyesters and device for implementation of the method'2007 7,115,701'Method for the continuous production of high-molecular polyester and device for carrying out the method'2006 6,868,286'Device for a transdermal and phonophoretic combination therapy and the use thereof in a method for medical application'2005 6,814,976'Transdermal therapeutic system comprising a reservoir-type pressure-sensitive adhesive layer and a back layer with uni-directional resilience'2004 6,627,631'Pharmaceutical composition containing desoxypeganine for the treatment of alcoholism'2003 6,617,452'Process for the isolation of galanthamine'2003 6,599,511'Pharmaceutical composition containing desoxypeganine for the treatment of drug dependence'2003 6,573,376'Process for the isolation of galanthamine'2003 6,558,696'Desoxypeganine'2003 6,548,510'Pharmaceutical composition containing deoxypeganine for the treatment of nicotine dependence'2003 6,436,937'Use of desoxypeganine in the treatment of Alzheimer\'s dementia'2002 6,417,365'Method for recovering medicaments from preparations, and from the precursors or wastes thereof'2002 6,344,211'Transdermal absorption of active substances from subcooled melts'2002 6,335,328'Process for the isolation of galanthamine'2002 6,315,854'Transdermal therapeutic plaster'2001 6,264,980'Transdermal resorption of active substances from supercooled masses of levulic acid'2001 6,194,404'Process for the isolation of galanthamine'2001 6,187,322'Process and a device for the production of a flat administration form comprising a preparation which contains pharmaceutical active substances'2001 6,114,347'Pharmaceutical formulation for the prophylaxis and pretreatment of a poisoning caused by organophosphorus cholinesterase inhibitors'2000 6,059,913'Method for producing transdermal patches (TTS)'2000 5,990,229'Adhesives with low level of residual monomers and process for manufacturing same'1999 5,965,155'Transdermal therapeutic system with pentylene tetrazol as active substance'1999 5,939,095'Transdermal therapeutic system and a process for the combined transdermal application of physostigmine and scopolamine for the prophylaxis and pretreatment of a poisoning caused by highly toxic organophosphorus neurotoxins in particular soman'1999 5,895,660'Deuterated active substances in transdermal application'1999 5,891,290'Method for the transfer of sections that are self-adhesive on one side from a moving first web onto a moving second web'1999 5,877,172'Process for isolating galanthamine'1999 5,869,086'Systems for the controlled release of pilocarpine'1999 5,705,186'Pharmaceutical composition for the systemic transdermal administration having the active substance morphine-6-glucuronide'1998 5,700,480'Transdermal therapeutic system comprising galanthamine as active component'1997 5,698,216'Transdermal therapeutic system for the administration of physostigmine to the skin and process for the production thereof'1997 5,681,413'Production of transdermal therapeutic systems'1997 5,391,375'Transdermal therapeutical system with physostigmine as active component and process for the production thereof'1995 5,240,711'Transdermal therapeutic system comprising as active component buprenorphine'1993 5,089,267'Transdermal therapeutical system comprising physostigmine as active component and process for the production thereof'1992

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1992–2015Patents assigned to LOHMANN THERAPIE SYST LTS (38)· patent assignee history

1992–2021Based in Neuwied, DE· patent location history

2006–2017Based in Berlin, DE· patent location history

2011–2020Patents assigned to HILLE THOMAS (10)· patent assignee history

2012–2016Based in Koblenz, DE· patent location history

2015–2020Patents assigned to MUELLER WALTER (3)· patent assignee history

2017–2021Patents assigned to LTS LOHMANN THERAPIE SYSTEME AG (5)· patent assignee history

2017Patents assigned to SK CHEMICALS CO LTD (3)· patent assignee history

2018Based in Dillenburg, DE· patent location history

2021Based in Kirchhundem, DE· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
LOHMANN THERAPIE SYST LTS	38	1992–2015
HILLE THOMASself	10	2011–2020
LTS LOHMANN THERAPIE SYSTEME AG	5	2017–2021
MUELLER WALTER	3	2015–2020
SK CHEMICALS CO LTD	3	2017

Locations

Location	Patents	Span
Neuwied, DE	44	1992–2021
Berlin, DE	6	2006–2017
Koblenz, DE	3	2012–2016
Kirchhundem, DE	1	2021
Dillenburg, DE	1	2018